Continuous-Infusion Verapamil With Etoposide in Relapsed or Resistant Paediatric Cancers

British Journal of Cancer- United Kingdom

doi 10.1038/bjc.1995.169

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

A Phase I Study of Intravenous Liposomal Daunorubicin (DaunoXome) in Paediatric Patients With Relapsed or Resistant Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2006English

873 Continuous Infusion Medication Safety in a Paediatric Intensive Care Unit

2017English

Pulmonary Toxicity in Paediatric Patients With Relapsed or Refractory Hodgkin Lymphoma Receiving Brentuximab Vedotin

British Journal of Haematology
Hematology
2018English

Long-Term Continuous Infusion of Anti-Gd2 Antibody CH14.18/CHO in Relapsed/Refractory Neuroblastoma Patients

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Paediatric Electronic Infusion Calculator: An Intervention to Eliminate Infusion Errors in Paediatric Critical Care

Journal of the Intensive Care Society
Critical Care NursingCritical CareIntensive Care Medicine
2016English

An Effective Modestly Intensive Re-Induction Regimen With Bortezomib in Relapsed or Refractory Paediatric Acute Lymphoblastic Leukaemia

British Journal of Haematology
Hematology
2018English

Ifosfamide/Vindesine Chemotherapy in Primarily Resistant or Relapsed Small Cell Lung Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

A Multi-Center Phase I Study of Clofarabine, Etoposide and Cyclophosphamide in Combination in Pediatric Patients With Refractory or Relapsed Acute Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Treatment of Obstructive Hypertrophic Cardiomyopathy Symptoms and Gradient Resistant to First-Line Therapy With -Blockade or Verapamil

Circulation. Heart failure
MedicineCardiovascular MedicineCardiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy